19 related articles for article (PubMed ID: 10924891)
1. Ancient origins of nitric oxide signaling in biological systems.
Durner J; Gow AJ; Stamler JS; Glazebrook J
Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14206-7. PubMed ID: 10588683
[No Abstract] [Full Text] [Related]
2. The Role of Single-Nucleotide Variants of
Shnayder NA; Petrova MM; Moskaleva PV; Shesternya PA; Pozhilenkova EA; Nasyrova RF
Molecules; 2021 Mar; 26(6):. PubMed ID: 33809023
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.
Hamza M; Dionne RA
Curr Mol Pharmacol; 2009 Jan; 2(1):1-14. PubMed ID: 19779578
[TBL] [Abstract][Full Text] [Related]
4. Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia.
Tassorelli C; Greco R; Sandrini G; Nappi G
Drugs; 2003; 63 Suppl 1():9-22. PubMed ID: 14506907
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test.
Aguirre-Bañuelos P; Granados-Soto V
Eur J Pharmacol; 2000 Apr; 395(1):9-13. PubMed ID: 10781667
[TBL] [Abstract][Full Text] [Related]
6. Participation of the nitric oxide-cyclic GMP-ATP-sensitive K(+) channel pathway in the antinociceptive action of ketorolac.
Lázaro-Ibáñez GG; Torres-López JE; Granados-Soto V
Eur J Pharmacol; 2001 Aug; 426(1-2):39-44. PubMed ID: 11525769
[TBL] [Abstract][Full Text] [Related]
7. Possible participation of the nitric oxide-cyclic GMP-protein kinase G-K+ channels pathway in the peripheral antinociception of melatonin.
Hernández-Pacheco A; Araiza-Saldaña CI; Granados-Soto V; Mixcoatl-Zecuatl T
Eur J Pharmacol; 2008 Oct; 596(1-3):70-6. PubMed ID: 18755181
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive effect of nimesulide.
Islas-Cadena M; Aguirre-Bañuelos P; Granados-Soto V
J Pharmacol Toxicol Methods; 1999 Oct; 42(2):87-92. PubMed ID: 10924891
[TBL] [Abstract][Full Text] [Related]
9. The in vivo assessment of nimesulide cyclooxygenase-2 selectivity.
Shah AA; Murray FE; Fitzgerald DJ
Rheumatology (Oxford); 1999 May; 38 Suppl 1():19-23. PubMed ID: 10369402
[TBL] [Abstract][Full Text] [Related]
10. Overview of nimesulide.
Bennett A
Rheumatology (Oxford); 1999 May; 38 Suppl 1():1-3. PubMed ID: 10369398
[No Abstract] [Full Text] [Related]
11. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
Famaey JP
Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
